Please login to the form below

Not currently logged in
Email:
Password:

Anish Mehta appointed CEO of new women's health business

Will head up the former Teva portoflio CVC Capital Partners recently acquired

Anish MehtaLondon-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the international women’s health assets portfolio it acquired from Teva Pharmaceuticals last month.

Mehta joins from Allergan, where he was head of international business development leading the team responsible for corporate development and licensing activity in support of the international business.

He said: “I am honoured to have this opportunity to partner with CVC and the existing team to lead this exciting new business.

The combination of high quality products and a talented team creates a unique opportunity for us to build a leading, global, speciality pharmaceutical business dedicated to women’s health.”

Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.

Cathrin Petty, partner and head of European Healthcare, CVC, said: “Anish is a well-established industry veteran, having spent over 20 years in the global healthcare space.

“His deep experience in M&A, complex carve outs and building businesses will be invaluable to us as we look to scale this business.”

19th October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics